Reinforcement-enhancing effects of nicotine
尼古丁的强化作用
基本信息
- 批准号:8087136
- 负责人:
- 金额:$ 18.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-15 至 2013-04-30
- 项目状态:已结题
- 来源:
- 关键词:AbstinenceAcuteAnhedoniaAnimal ExperimentationAnimal ModelAnimalsChronicCigaretteComputersDependenceDevelopmentEnvironmentFailureFamiliarityFutureHumanIntakeLeadLinkMental DepressionMusicNicotineNicotine DependenceNoisePharmaceutical PreparationsProceduresPsychological reinforcementRelapseResearchResearch Project GrantsRewardsRodentSelf-AdministeredSex CharacteristicsSmokerSmokingSmoking BehaviorStimulusSumUnited States National Institutes of HealthWithdrawalWithholding TreatmentWomanWorkcigarette smokingdesignimprovedmenpreventprogramsreinforcersmoking cessationsuccess
项目摘要
DESCRIPTION (provided by applicant): "Reinforcement-enhancing effects of nicotine" Nicotine clearly has primary and secondary reinforcing effects in humans and animal models. Very recent research in rodents indicates that nicotine may also have a third reinforcing function; that of reinforcement-enhancing effects, or increasing the reinforcing efficacy of rewards unrelated to nicotine intake. This R21 application seeks to determine whether nicotine via smoking has reinforcement enhancing effects in humans. One hundred smokers, 50 nicotine dependent and 50 nondependent, will participate in 4 experimental sessions, involving: 1) smoking nicotine (0.6 mg) cigarettes or 2) smoking denic (0.05 mg) cigarettes or 3) no smoking, each after overnight abstinence, or 4) smoking their own brand after no overnight abstinence (exploratory condition). In each session, they will respond on a simple operant task for small amounts of money, brief access to preferred music, avoidance of aversive white noise, or no reward (control). Our primary specific aim is to examine the influence of nicotine via smoking on responding for rewards. We hypothesize that reinforced responding will be greater after smoking a nicotine vs a denic cigarette (and vs. no smoking), indicating reinforcement enhancing effects of nicotine per se. Effects of nicotine on responding for some rewards versus others or no reward will indicate that reinforcement enhancement due to nicotine is specific to certain rewards and not a generalized effect of nicotine intake. Reinforcement-enhancing effects of nicotine in nondependent smokers, as well as dependent smokers, would suggest that these effects do not require the establishment of dependence and reflect absolute enhancement of reinforcement, as observed in the rodent studies. Substantial pilot work supports project feasibility and points to the likelihood of these hypothesized results. By contrast, if effects are observed only in dependent and not nondependent smokers, they could reflect withdrawal relief and not true enhancement of reinforcement. A secondary aim is to explore sex differences in the reinforcement enhancing effects of nicotine. This research is highly significant because demonstrating reinforcement-enhancing effects of nicotine in humans would have very important implications for our understanding of nicotine dependence. It would indicate that smoking does not "just" provide reinforcement from direct psychoactive effects of nicotine but rather broadly increases the reinforcing effects of the other rewards in a smoker's environment. Therefore, quitting smoking would result in a loss of this broad reinforcement, in addition to loss of nicotine's psychoactive effects. This broad reinforcement loss could be restored by smoking one cigarette (i.e. a lapse), helping to explain the persistence of smoking behavior. Results would provide directions for improving cessation treatments. This R21 submission fits the requirements of PA-10-069, "NIH Exploratory Developmental Research Grant Program."
PUBLIC HEALTH RELEVANCE: "Reinforcement enhancing effects of nicotine" This project will determine whether nicotine via cigarette smoking increases the reinforcing value of other rewards unrelated to smoking, as indicated by recent rodent studies. Dependent and nondependent smokers will work on a computer task to earn various small rewards after smoking nicotine or denic cigarettes or not smoking. This research is highly significant because demonstrating reinforcement-enhancing effects of nicotine in humans would have very important implications for our understanding of nicotine dependence. It would indicate that smoking does not "just" provide reinforcement from direct psychoactive effects of nicotine, but rather broadly increases the reinforcing effects of the other rewards in a smoker's environment. Therefore, quitting smoking could result in a loss of this broad reinforcement, in addition to loss of nicotine's psychoactive effects. This broad reinforcement loss could be restored by smoking a cigarette (i.e. a lapse), helping to explain why a lapse almost invariably leads to relapse after a quit attempt.
描述(由申请人提供):“尼古丁的增强作用”尼古丁在人类和动物模型中明显具有主要和次要的增强作用。最近对啮齿动物的研究表明,尼古丁还可能具有第三种强化功能;即增强食欲的作用,或增加与尼古丁摄入无关的奖励的强化功效。这项R21申请旨在确定通过吸烟的尼古丁是否对人类具有强化增强作用。100名吸烟者(50名尼古丁依赖者和50名非依赖者)将参加4个实验阶段,包括:1)吸烟尼古丁(0.6 mg)香烟或2)吸烟denic(0.05 mg)香烟或3)戒烟,均在整夜戒烟后,或4)在整夜戒烟后吸烟自己的品牌(探索性条件)。在每一阶段,他们将对一个简单的操作性任务做出反应,条件是少量的钱,短暂地接触喜欢的音乐,避免令人厌恶的白色噪音,或者没有奖励(控制)。我们的主要具体目标是研究尼古丁通过吸烟对奖励反应的影响。我们假设,吸烟尼古丁后的强化反应将大于非吸烟香烟(和不吸烟),表明尼古丁本身的强化增强效应。尼古丁对某些奖励与其他奖励或无奖励的反应的影响表明,尼古丁引起的强化增强是特定于某些奖励的,而不是尼古丁摄入的普遍效应。尼古丁在非依赖性吸烟者和依赖性吸烟者中的强化增强作用表明,这些作用不需要建立依赖性,而是反映了强化的绝对增强,如啮齿动物研究中所观察到的那样。大量的试点工作支持项目的可行性,并指出这些假设结果的可能性。相比之下,如果仅在依赖性吸烟者而非依赖性吸烟者中观察到效果,则它们可能反映了戒断缓解,而不是真正的强化增强。第二个目的是探索尼古丁强化增强效应的性别差异。这项研究非常重要,因为证明尼古丁在人类中的增强作用将对我们理解尼古丁依赖具有非常重要的意义。这表明,吸烟并不“只是”提供尼古丁直接精神作用的强化,而是广泛地增加了吸烟者环境中其他奖励的强化作用。因此,戒烟将导致这种广泛的强化作用的丧失,以及尼古丁的精神活性作用的丧失。这种广泛的强化损失可以通过吸一支烟(即一次失误)来恢复,这有助于解释吸烟行为的持续性。研究结果将为改善戒烟治疗提供指导。本R21申报符合PA-10-069“NIH探索性发展研究资助计划”的要求。"
公共卫生关系:“尼古丁的强化增强作用”本项目将确定通过吸烟产生的尼古丁是否会增加与吸烟无关的其他奖励的强化价值,正如最近的啮齿动物研究所表明的那样。依赖性和非依赖性吸烟者将工作在一个计算机任务,以赚取各种小奖励后,吸烟尼古丁或丹麦香烟或不吸烟。这项研究非常重要,因为证明尼古丁在人类中的增强作用将对我们理解尼古丁依赖具有非常重要的意义。这表明,吸烟并不“仅仅”提供尼古丁直接精神作用的强化,而是广泛地增加了吸烟者环境中其他奖励的强化作用。因此,戒烟可能会导致这种广泛的强化作用的丧失,以及尼古丁的精神活性作用的丧失。这种广泛的强化损失可以通过吸烟(即失误)来恢复,这有助于解释为什么失误几乎总是导致戒烟尝试后的复发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH Alan PERKINS其他文献
KENNETH Alan PERKINS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH Alan PERKINS', 18)}}的其他基金
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10452567 - 财政年份:2021
- 资助金额:
$ 18.94万 - 项目类别:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10620310 - 财政年份:2021
- 资助金额:
$ 18.94万 - 项目类别:
First-in-Human Clinical Development of a Novel Drug Candidate with a First-in-Class Mechanism for Smoking Cessation and Abstinence
具有一流戒烟和节欲机制的新候选药物的首次人体临床开发
- 批准号:
10328576 - 财政年份:2021
- 资助金额:
$ 18.94万 - 项目类别:
Threshold Dose for Nicotine Discrimination in Cigarettes
香烟中尼古丁歧视的阈剂量
- 批准号:
8573038 - 财政年份:2013
- 资助金额:
$ 18.94万 - 项目类别:
Threshold Dose for Nicotine Discrimination in Cigarettes
香烟中尼古丁歧视的阈剂量
- 批准号:
8720746 - 财政年份:2013
- 资助金额:
$ 18.94万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 18.94万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 18.94万 - 项目类别:
Operating Grants














{{item.name}}会员




